South Korea’s Latest Biotech Billionaire Made on AI Cancer Drugs
A South Korean biotech company with virtually no revenue has seen its shares skyrocket 190% this year, making its CEO a billionaire. Voronoi’s AI-powered cancer drug pipeline has investors betting big on early-stage treatments targeting breast cancer and lung cancer. The company just started Phase 1